Downloads provided by UsageCounts
handle: 10261/244577 , 10261/244582
La presente invención se refiere al uso de efavirenz para fabricar un medicamento para el tratamiento de enfermedades de almacenamiento lipídico tales como enfermedades de Niemann-Pick . Mediante la activación de CYP46, que estimula la eliminación de colesterol en las neuronas , entre otros lípidos ,efavirenz es capaz de normalizar los niveles de estos lípidos y la función neuronal. Efavirenz también se puede usar en combinación con otro principio activo considerado eficaz para el tratamiento de estas enfermedades, para mejorar los efectos terapéuticos
A1 Solicitud de patente con informe sobre el estado de la técnica
Consejo Superior de Investigaciones Científicas (España)
Peer reviewed
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 58 | |
| downloads | 93 |

Views provided by UsageCounts
Downloads provided by UsageCounts